nitroglycerin has been researched along with probenecid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ignarro, LJ; Wood, KS | 1 |
| Kolassa, N; Pfleger, K; Volkmer, I | 1 |
| Hunter, FE; Irwin, C; O'Brien, JK; Stein, RL; Townsend-Parchman, JK | 1 |
| Chadaide, Z; Fenyo, R; Knyihár-Csillik, E; Krisztin-Péva, B; Mihály, A; Németh, H; Toldi, J; Vécsei, L | 1 |
| Chadaide, Z; Fenyo, R; Knyihár-Csillik, E; Krisztin-Péva, B; Németh, H; Toldi, J; Vécsei, L | 1 |
| Bohár, Z; Fülöp, F; Párdutz, A; Tajti, J; Toldi, J; Vámos, E; Varga, H; Vécsei, L | 1 |
| Fejes, A; Pardutz, A; Tajti, J; Toldi, J; Vamos, E; Vecsei, L | 1 |
1 review(s) available for nitroglycerin and probenecid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for nitroglycerin and probenecid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase.
Topics: 1-Methyl-3-isobutylxanthine; Acetaminophen; Acetylcysteine; Animals; Cyclic AMP; Cyclic GMP; Guanylate Cyclase; Heme; Liver; Methylnitronitrosoguanidine; Mice; Nitroglycerin; Penicillamine; Phenobarbital; Phenylhydrazines; Potassium Cyanide; Probenecid; Protoporphyrins; Purinones; S-Nitroso-N-Acetylpenicillamine | 1987 |
[Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
Topics: Alkaloids; Allopurinol; Animals; Carbon Isotopes; Cocaine; Depression, Chemical; Dipyridamole; Drug Synergism; Ethylenediamines; Guinea Pigs; Heart Rate; In Vitro Techniques; Myocardium; Nitroglycerin; Nucleosides; Ouabain; Papaverine; Prenylamine; Probenecid; Pyridines; Reserpine; Stimulation, Chemical; Theophylline; Triamterene; Vasodilator Agents; Verapamil | 1969 |
Extension of the blood half-life of glyceryl trinitrate. Inhibition of glutathione organic nitrate ester reductase activity in the rat and guinea pig.
Topics: Animals; Cephalothin; Female; Glutathione Transferase; Guinea Pigs; Half-Life; In Vitro Techniques; Kinetics; Liver; Nitroglycerin; Penicillin G; Probenecid | 1980 |
Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Genes, fos; Immunohistochemistry; Kynurenine; Male; Migraine Disorders; Neurons; Nitroglycerin; Probenecid; Rats; Rats, Wistar; Trigeminal Caudal Nucleus; Vasodilator Agents | 2007 |
Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.
Topics: Adjuvants, Pharmaceutic; Afferent Pathways; Analgesics; Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Synergism; Electric Stimulation; Immunohistochemistry; Kynurenine; Male; Migraine Disorders; Neurons, Afferent; Nitroglycerin; Nociceptors; Probenecid; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Synaptic Transmission; Treatment Outcome; Trigeminal Caudal Nucleus; Vasodilator Agents | 2007 |
l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
Topics: Animals; Central Nervous System Agents; Cervical Vertebrae; Drug Synergism; Kynurenic Acid; Kynurenine; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitroglycerin; Probenecid; Quinolones; Rats; Rats, Sprague-Dawley; Spinal Cord; Time Factors; Trigeminal Nuclei | 2009 |
Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Gene Expression Regulation; Male; Nitric Oxide Synthase Type I; Nitroglycerin; Probenecid; Rats; Rats, Sprague-Dawley; Trigeminal Caudal Nucleus | 2009 |